Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap Verweij

Showing results (71-80 of 234) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Clinical pharmacokinetics of irinotecan and its metabolites: a population analysisRujia Xie, Ron H J Mathijssen, Alex Sparreboom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxelCarolien H Smorenburg, Alex Sparreboom, Marijke Bontenbal, et al.
Investigational New Drugs|May 4, 2004
Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patientsAlex Sparreboom, Sharon Marsh, Ron H J Mathijssen, et al.
Clinical Pharmacology and Therapeutics|October 10, 2003
Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteinsWalter J Loos, Sharyn D Baker, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic studyJos J Kitzen, Christian Puozzo, Maja J de Jonge, et al.
Sarcoma|June 4, 2008
Low Dose Methotrexate and Vinblastine, Given Weekly to Patients With Desmoid Tumours, is Associated With Major ToxicityRené L van der Hul, Caroline Seynaeve, Bert N van Geel, et al.
Analytical Biochemistry|July 13, 2004
Determination of fraction unbound docetaxel using microequilibrium dialysisMilin R Acharya, Sharyn D Baker, Jaap Verweij, et al.
Journal of the National Cancer Institute|August 22, 2002
Effects of St. John's wort on irinotecan metabolismRon H J Mathijssen, Jaap Verweij, Peter de Bruijn, et al.
Current Clinical Pharmacology|August 1, 2008
The relevance of microdialysis for clinical on:cologyJos J E M Kitzen, Jaap Verweij, Erik A C Wiemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Flat-fixed dosing of irinotecan: influence on pharmacokinetic and pharmacodynamic variabilityFloris A de Jong, Ron H J Mathijssen, Rujia Xie, et al.
Pageof 24

Showing results (71-80 of 234) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Clinical pharmacokinetics of irinotecan and its metabolites: a population analysisRujia Xie, Ron H J Mathijssen, Alex Sparreboom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2003
Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxelCarolien H Smorenburg, Alex Sparreboom, Marijke Bontenbal, et al.
Investigational New Drugs|May 4, 2004
Pharmacogenetics of tipifarnib (R115777) transport and metabolism in cancer patientsAlex Sparreboom, Sharon Marsh, Ron H J Mathijssen, et al.
Clinical Pharmacology and Therapeutics|October 10, 2003
Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteinsWalter J Loos, Sharyn D Baker, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2009
Mild to moderate liver dysfunction does not require dose reduction of oral or intravenous vinorelbine: results of a pharmacokinetic studyJos J Kitzen, Christian Puozzo, Maja J de Jonge, et al.
Sarcoma|June 4, 2008
Low Dose Methotrexate and Vinblastine, Given Weekly to Patients With Desmoid Tumours, is Associated With Major ToxicityRené L van der Hul, Caroline Seynaeve, Bert N van Geel, et al.
Analytical Biochemistry|July 13, 2004
Determination of fraction unbound docetaxel using microequilibrium dialysisMilin R Acharya, Sharyn D Baker, Jaap Verweij, et al.
Journal of the National Cancer Institute|August 22, 2002
Effects of St. John's wort on irinotecan metabolismRon H J Mathijssen, Jaap Verweij, Peter de Bruijn, et al.
Current Clinical Pharmacology|August 1, 2008
The relevance of microdialysis for clinical on:cologyJos J E M Kitzen, Jaap Verweij, Erik A C Wiemer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Flat-fixed dosing of irinotecan: influence on pharmacokinetic and pharmacodynamic variabilityFloris A de Jong, Ron H J Mathijssen, Rujia Xie, et al.
Pageof 24